Intensity Therapeutics director granted 5,500 stock options

Intensity Therapeutics, Inc. reported that director Emer Leahy received a grant of stock options covering 5,500 shares of common stock at an exercise price of $4.90 per share.

Rhea-AI Filing Summary

Intensity Therapeutics, Inc. reported that director Emer Leahy received a grant of stock options covering 5,500 shares of common stock at an exercise price of $4.90 per share. The options vest in four equal annual installments beginning July 16, 2026, subject to continued service, and expire July 16, 2036, leaving Leahy with options on 5,500 shares in total.

Insider Trade Summary

Grant/Award: 5,500 shares

Grant/Award 1 txn

Insider Leahy Emer

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy Common Stock) F1	5,500	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy Common Stock) — 5,500 contracts (Direct)

Footnotes (1)

1. F1. This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026.

Key Figures

Options Granted: 5,500 shares Exercise Price: $4.90 per share Underlying Shares: 5,500 shares +3 more

6 metrics

Options Granted 5,500 shares Stock options granted to director Emer Leahy

Exercise Price $4.90 per share Exercise price of the stock option grant

Underlying Shares 5,500 shares Common stock underlying the option grant

Vesting Start Date July 16, 2026 First vesting date, in four equal annual installments

Expiration Date July 16, 2036 Expiration of the stock options

Options Held After Grant 5,500 shares Total derivative holdings following this transaction

Key Terms

Stock Option (right to buy Common Stock), exercise price, vest, expiration date

4 terms

Stock Option (right to buy Common Stock) financial

"security_title: Stock Option (right to buy Common Stock)"

exercise price financial

"conversion_or_exercise_price of $4.9000 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"This option will vest in four, equal, annual installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

expiration date financial

"expiration_date reported as 2036-07-16 for the option"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Intensity Therapeutics (INTS) report for Emer Leahy?

Emer Leahy received a grant of stock options for 5,500 shares of Intensity Therapeutics common stock at an exercise price of $4.90 per share. The award is a compensation grant, not an open-market trade, and will vest over four years starting July 16, 2026.

How many Intensity Therapeutics (INTS) shares are covered by Emer Leahy's new stock options?

The option grant covers 5,500 shares of common stock as the underlying security. Following this award, Leahy holds options on 5,500 shares in total according to the reported post-transaction holdings in the insider transaction data.

What is the exercise price and term of Emer Leahy's Intensity Therapeutics (INTS) stock options?

The options have an exercise price of $4.90 per share and an expiration date of July 16, 2036. This gives a long-dated right to buy Intensity Therapeutics common stock at that price if the options vest and are later exercised.

When do Emer Leahy's Intensity Therapeutics (INTS) stock options vest?

The options vest in four equal annual installments beginning on July 16, 2026, as long as Leahy continues serving with Intensity Therapeutics. Each year, one quarter of the 5,500 options becomes exercisable until the full grant is vested.

Is Emer Leahy's Intensity Therapeutics (INTS) option grant a market purchase of shares?

No. The transaction is classified as a grant or award acquisition of stock options with a per-share exercise price of $4.90 and a reported transaction price of $0.00. It reflects equity compensation, not a purchase of existing shares in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 04:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leahy Emer

(Last) (First) (Middle)

C/O INTENSITY THERAPEUTICS, INC.

1 ENTERPRISE DRIVE, SUITE 430

(Street)

SHELTON CONNECTICUT 06484

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTENSITY THERAPEUTICS, INC. [ INTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy Common Stock)	$4.9	07/16/2026		A		5,500		07/16/2026(1)	07/16/2036	Common Stock	5,500	$0	5,500	D

Explanation of Responses:

1. This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026.

Remarks:

	/s/ Kostantinos Skordalos, Attorney-in-fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)